R&D Projects

Confirmed projects database queries

The information may be unavailable due to the results not being approved or confirmed. In particular, when a call includes regions where projects are cofunded by EC funds and others where that is not the case, confirmation or approval may be not simultaneous.

Call for Funding of Research and Development Projects in all Scientific Domains - 2009

Health Sciences - Biomaterials

Painel de Avaliação da área das Ciências da Saúde - 2009

Fernando Giraldez Orgaz
Jean-Michel Bouler
Sergio Cerutti
Geert van der Heijden
Ad Geurts van Kessel
Caetano Reis e Sousa
George Griffin
Roland Pochet
Louis Lemieux
Stephen Paul Hilary Alexander
Peter Illes
Humphrey Hodgson
Rolf Jackisch
Marc Mareel
Maxime GUYE
Marc Moreau
Bruno Bujoli
Derek Macallan
Andrew Westwell
John Martin
Gordon Stewart
Robert Hofstra
Maurice Zeegers
Gerard J te Meerman
Geert Martens
Jean Vanderpas
Mark Van de Casteele

PTDC/SAU-BMA/109886/2009: Skin2: a biosynthetic second skin, engineered to treat severe burn wounds. Jorge Alexandre Monteiro de Carvalho e Silva, NOVA.ID.FCT - Associação para a Inovação e Desenvolvimento da FCT (NOVA.ID.FCT). €160,000.
PTDC/SAU-BMA/111233/2009: Nanohydroxyapatite antibacterial surfaces to prevent biofilm associated bone infection (NaNOBiofilm). MARIA PIA DE MELO ALVIM FERRAZ TAVARES, Instituto Nacional de Engenharia Biomédica - INEB Univ. Porto (INEB Porto). €150,000.
PTDC/SAU-BMA/113030/2009: GIANTCELL - The modulation of macrophages to resolve inflammatory reactions to biomaterials through the induction of the M2 phenotype. Maria Judite Tavares Moreira Novais Barbosa, Instituto Nacional de Engenharia Biomédica - INEB Univ. Porto (INEB Porto). €115,000.
PTDC/SAU-BMA/114059/2009: Intracellular Drug Delivery Systems and Tissue Engineering as a Combinatory Approach for Spinal Cord Injury Regeneration. António José Braga Osório Gomes Salgado, Universidade do Minho (UM). €165,000.
PTDC/SAU-BMA/114482/2009: Development of a novel therapeutic strategy for pancreatic cancer involving a concerted action of gene therapy and chemotherapeutic agents. Henrique Manuel Santos Faneca, Centro de Neurociências e Biologia Celular (CNBC/UC). €100,000.